Peter T Slover

CIK 1468012 · Chief Financial Officer · last filed 2026-01-30

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

3

Total Filings

15

Lifetime Open-Market Net

$19.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
CTNM	Chief Financial Officer	—	$11.88	—	$0	3	2026-01-30
SOPHIRIS BIO INC. (SPHS) Delisted	Chief Financial Officer	4,680	—	—	$19.9K	8	2019-12-23
ANADYS PHARMACEUTICALS INC (ANDS) Delisted	VP, Finance and Operations	—	—	—	$0	4	2011-01-24

Recent Filings · Page 2 of 2

15 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2013-08-20	SOPHIRIS BIO INC. (SPHS) Delisted	Buy (P)	+4,680	$19.9K	EDGAR
2011-01-24	ANADYS PHARMACEUTICALS INC (ANDS) Delisted	Grant (A)	—	$0	EDGAR
2010-12-15	ANADYS PHARMACEUTICALS INC (ANDS) Delisted	Grant (A)	—	$0	EDGAR
2009-12-07	ANADYS PHARMACEUTICALS INC (ANDS) Delisted	Grant (A)	—	$0	EDGAR
2009-08-20	ANADYS PHARMACEUTICALS INC (ANDS) Delisted	Grant (A)	—	$0	EDGAR

Showing 11–15 of 15

Prev Page 2 of 2

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.